EDRS
ANTH

Edmond de Rothschild (Suisse)’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$5K Hold
188
– – ﹤0.01% 439
2016
Q2 		$5K Hold
188
– – ﹤0.01% 409
2016
Q1 		$5K Sell
188
-1,250
-87% -$33.9K ﹤0.01% 365
2015
Q4 		$53K Buy
1,438
+63
+5% +$2.78K 0.02% 239
2015
Q3 		$67K Sell
1,375
-500
-27% -$34.9K 0.02% 242
2015
Q2 		$129K Buy
+1,875
New +$86.8K 0.04% 198

Other funds holding ANTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s ANTH Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) held its Anthera Pharmaceuticals, Inc. (ANTH) position steady in Q3 2016 at 188 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Edmond de Rothschild (Suisse) first reported a position in ANTH in Q2 2015 and has held it in 6 quarters since. The position peaked at $129K in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q3 2016.

  • Edmond de Rothschild (Suisse) held 188 shares of Anthera Pharmaceuticals, Inc. worth $5K as of Q3 2016.
  • Edmond de Rothschild (Suisse) left its Anthera Pharmaceuticals, Inc. share count unchanged in Q3 2016.
  • Anthera Pharmaceuticals, Inc. made up ﹤0.01% of Edmond de Rothschild (Suisse)'s portfolio in Q3 2016, its #439 holding.
  • Edmond de Rothschild (Suisse) first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2015 and has held it in 6 quarters since.
  • Edmond de Rothschild (Suisse)'s Anthera Pharmaceuticals, Inc. position peaked at $129K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.